Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACER: Guideline Treatment vs TAU in Adolescent Schizophrenia
NCT02573701Completed
- Sponsor
- Hospital Psiquiátrico Infantil Dr. Juan N. Navarro
- Start
- Oct 2011
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of risperidone in schizophrenia (2 arms), sponsored by Hospital Psiquiátrico Infantil Dr. Juan N. Navarro. Primary endpoint: Responder status (>30% reduction in PANSS score and improvement on CGI score) at 6 months. Started Oct 2011; status: completed.
02
Drugs
risperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02573701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02573701.